Ankasa Regenerative Therapeutics, Inc. — Form D
Ankasa Regenerative Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-14. The offering totals $12.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-10-14
- Form: D
- Accession: 0001646162-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $6.0M
- Remaining: $6.0M
- Investors: 4
- Date of first sale: 2020-09-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-377785
Issuer
- Name: Ankasa Regenerative Therapeutics, Inc.
- CIK: 0001646162
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 11099 N. TORREY PINES ROAD, LA JOLLA, CA, 92037
- Phone: 858 750 4700
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Kevin J Kinsella | Director | Boston, MA |
| Andre J Kobelt, Ph.D. | Director | La Jolla, CA |
| Sanford J Madigan | Director | La Jolla, CA |
| Sanford J Madigan | Executive Officer | La Jolla, CA |
| Tighe J Reardon | Executive Officer | La Jolla, CA |
| Douglas J Downs | Director | La Jolla, CA |
| Douglas J Downs | Executive Officer | La Jolla, CA |
Other filings by this issuer (1)
More